Research never stops

Top Story

Evotec and MaRS Innovation announce first funded project under LAB150 BRIDGE

Hamburg, Germany, and Toronto, Canada, 15 February 2018:
Evotec AG and MaRS Innovation announced today that they have identified the first project to be developed under their LAB150 partnership.

- read more

Evotec and APEIRON achieve first milestone in immuno-oncology alliance with Sanofi

Hamburg, Germany and Vienna, Austria, 08 January 2018:
Evotec AG and APEIRON Biologics AG, a company focused on cancer immunotherapy, announced today that the companies received the first milestone payment

- read more

Evotec to attend upcoming investor conferences

Hamburg, Germany, 03 January 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting

- read more
loading weather report
Loading weather report...

Events

Feb 27, 2018 - CED Life Science Conference

Mar 13, 2018 - 24th Prior Kapitalmarktkonferenz

Company Presentation February

Building integrated and high-value drug discovery alliances
2018-02_Evotec_Company presentation_February